Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1694 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-09-12 | 2020-03-16 | 61368 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68626 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2020-07-16 | 2020-11-07 | 120494 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2022-11-14 | 2023-02-09 | 174607 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-02-16 | 2023-06-09 | 184937 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-06-20 | 2023-07-28 | 195789 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2018-03-13 | 2018-07-30 | 42638 |
FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2019-06-27 | 2019-08-29 | 87668 |
FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2019-08-22 | 2019-10-04 | 92143 |
FENTORA | 100MCG | TABLET (EFFERVESCENT) | Resolved | 2020-11-19 | 2021-02-05 | 128600 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2021-03-04 | 2021-03-18 | 135114 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-07-08 | 2021-10-14 | 142198 |
FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146115 |
FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146125 |
FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2023-04-27 | 2023-06-21 | 190698 |
FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2023-06-08 | 2023-10-04 | 194172 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ARIPIPRAZOLE | 10MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117535 |
TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117538 |
TEVA-ARIPIPRAZOLE | 30MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117541 |
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Discontinued | 2020-01-21 | 2020-01-21 | 103781 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 |